Steven Dresner Md Inc is categorized under Ophthalmologists in Los Angeles, CA and active since 1992.
Steven Dresner Md Inc was established in 1992, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Ophthalmologists business, which does work in the B2C market, and is classified as a Ophthalmologists, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Steven Dresner at the company’s headquarters by writing to 1513 South Grand Avenue # 200, Los Angeles, California CA 90015 or by phoning (310) 453-1763. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Steven Dresner Md Inc |
| Contact Person: | Steven Dresner |
| Address: | 1513 South Grand Avenue # 200, Los Angeles, California 90015 |
| Phone Number: | (310) 453-1763 |
| Website Address: | eyesthetica.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1992 |
| Location Type: | Headquarters |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Ophthalmologists |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Steven Dresner Md Inc was started in 1992 to provide professional Ophthalmologists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Steven Dresner for inquiries that concern Steven Dresner Md Inc by calling the company number (310) 453-1763, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Steven Dresner Md Inc can be found at the coordinates 34.036124,-118.266258 as well as the street address 1513 South Grand Avenue # 200 in Los Angeles, California 90015.
For its online presence, you may visit Steven Dresner Md Inc’s website at eyesthetica.com and engage with its social media outlets through on Twitter and on Facebook.